{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_plasma_exchange",
          "name": "Plasma exchange"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_complement_inhibitors",
          "name": "Complement Inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_supportive_care",
          "name": "Supportive care"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_acanthopanax",
          "name": "Acanthopanax"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_tolvaptan",
          "name": "Tolvaptan"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_immunosuppressants",
          "name": "Immunosuppressants"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_antiplatelet_drugs",
          "name": "Antiplatelet drugs"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_cytokine_inhibitors",
          "name": "Cytokine inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_anticoagulants",
          "name": "Anticoagulants"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasma_exchange",
          "type": "Drug",
          "label": "Plasma exchange",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_complement_inhibitors",
          "type": "Drug",
          "label": "Complement Inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_supportive_care",
          "type": "Drug",
          "label": "Supportive care",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_ahus",
          "type": "Disease",
          "label": "Atypical haemolytic uraemic syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_eculizumab",
          "target": "disease_ahus",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "临床应用支持，针对 complement 系统"
        },
        {
          "source": "drug_ravulizumab",
          "target": "disease_ahus",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "新型 complement 抑制剂在 AHUS 中的应用"
        },
        {
          "source": "drug_plasma_exchange",
          "target": "disease_ahus",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "常规治疗方法，临床知晓度高"
        },
        {
          "source": "drug_complement_inhibitors",
          "target": "disease_ahus",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与 AHUS 相关的靶向疗法"
        },
        {
          "source": "drug_supportive_care",
          "target": "disease_ahus",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "支持性治疗有助于改善症状"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物显示出对 Atypical haemolytic uraemic syndrome 的支持作用",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "上述药物声明为 Atypical haemolytic uraemic syndrome 的指示药物"
    ],
    "uncertainties": [
      "对新药物 long-term 数据缺乏明确性"
    ],
    "next_focus_for_pi": [
      "确定是否需要探索其他候选治疗和更详细的机制"
    ]
  }
}